Vojenské Rozhledy

Czech Military Review

Vojenské rozhledy / Czech Military Review Nr. 2/2011: 130-135

The Preventive Aspects of the Overweight and Obesity in the Army of the Czech RepublicInformational pages

Pplk. MUDr. Pavlík Vladimír Ph.D., pplk. MUDr. Jana Fajfrová, kpt. MUDr. Michaela Husárová, doc. MUDr. Pavol Hlúbik Pavol CSc.

The problem of obesity is most frequent metabolic disease rising from unhealthy life style of contemporary population. Cardiovascular and metabolic disorders are pressing even in the AČR, so the authors could describe monitoring the risk factors of non-infectious diseases of mass incidence and the implementation of preventive programme with excessive weight losses, using dietetic, psychological, movements and pharmacological approaches that offer real stimulant for decrease in overweight and obesity prevalence within the Czech Army and concurrently decrease in morbidity of Czech servicemen.

Keywords: armed forces of the czech republic,prevention,state of health

Published: June 15, 2011  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Vladimír, P., Fajfrová, J., Husárová, M., & Hlúbik Pavol, P. (2011). The Preventive Aspects of the Overweight and Obesity in the Army of the Czech Republic. Czech Military Review92(2), 130-135
Download citation

References

  1. Hainer V. Základy klinické obezitologie, Praha: Avicenum, 2004.
  2. Reaven P. Metabolic syndrome. In J. Insur. med., 2004, 36: 132-142.
  3. Chaloupka J., Býma S., Hlúbik P. Rozšířená preventivní péče - Vybrané výsledky programu rozšířené preventivní péče v AČR. In Vojenské zdravotnické listy, 2000, vol. 69, č. 2, s. 57-62.
  4. Střítecká H., Hlúbik P. Program rozšířené prevence Armády České republiky. In Hygiena, 2009, 54(4):117-121.
  5. Kabrnová A., Hainer V. Vliv nutričních faktorů na úspěšnost redukčních režimů. In Časopis lékařů českých, 2005, 144: 529-533.
  6. James W.P., Caterson I.D., Coutinho W. et al. Effect of sibutramine on cardiovascular outcomes in overweight and obese subjects. In New England Journal of Medicine, 2010, 363 (10): 905-17.
  7. Torp-Pedersen C., Caterson I., Coutinho W. et al. Cardiovascular responses to weight management and sibutramine in high-risk subjects: an analysis from the SCOUT trial. In European Heart Journal, 2007, Dec., 28 (23): 2915-23.
  8. Minarčíková I. Farmakoekonomické aspekty ve farmakoterapii obezity. In Česká a slovenská farmacie, 2003, 52: 258-261.